Maxillomandibular Advancement for Obstructive Sleep Apnea in Patients With Obesity: A Meta‐Analysis

Tanner J. Diemer,Douglas P. Nanu,Shaun A. Nguyen,Badr Ibrahim,Ted A. Meyer,Mohamed Abdelwahab
DOI: https://doi.org/10.1002/lary.31751
IF: 2.97
2024-09-13
The Laryngoscope
Abstract:This systematic review examined the effects of maxillomandibular advancement (MMA) on obstructive sleep apnea (OSA) patients with obesity, including 14 studies with 143 subjects. Significant improvements were observed in apnea‐hypopnea index (AHI), lowest oxygen saturation (LSAT), and Epworth Sleepiness Scale (ESS), with surgical success and cure rates at 85.6% and 39.2%, respectively. Notably, patients with class 3 obesity showed a significantly greater percent reduction in AHI compared to those with class 1 and 2 obesity. Objective To systematically review polysomnographic and cephalometric data in obstructive sleep apnea (OSA) patients with obesity (body mass index [BMI] ≥30 kg/m2) treated with maxillomandibular advancement (MMA). Data Sources Scopus, PubMed, CINAHL, and The COCHRANE Library. Review Methods A search was performed from inception until April 3, 2024, in each database. Results A total of 14 studies (143 subjects) were included. The mean age was 44.3 years (range: 17–69), 80.2% males (95% CI: 72.5–86.5), mean BMI of 35.3 (95% CI: 33.1–37.5), and mean duration to follow‐up post‐MMA was 13.7 months (95% CI: 10.1–17.3). All objective outcomes improved significantly; overall, apnea‐hypopnea index (AHI) decreased by −57.3 ([95% CI: −71.5 to −43.2], p
medicine, research & experimental,otorhinolaryngology
What problem does this paper attempt to address?